Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. MLAB | 0.00 |
Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:
MLAB) with a Equal-Weight and raises the price target from $94 to $110.